National Cancer Center Hospital East

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Kanagawa Cancer Center2
2. Roche (China)中国1
3. Wakayama Medical University日本1
4. Kanazawa University Hospital日本1
5. Toranomon Hospital Kajigaya日本1
6. Chugai Pharmaceutical Co., Ltd. (Japan)日本1
7. The Cancer Institute Hospital日本1
8. Genentech1

按月发文

逐年被引

最新文献

1. 1
   D-dimer for screening of aortic dissection in patients with ST-elevation myocardial infarctionAmerican Journal of Emergency Medicine202211
2. 2
   Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factorsExpert Opinion on Drug Safety202121
3. 3
   Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidineExpert Opinion on Drug Safety20204
4. 4
   Optimal management of patients with hepatocellular carcinoma treated with lenvatinibExpert Opinion on Drug Safety201839
5. 5
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758

高被引文献

1. 1
   Erlotinib Plus Bevacizumab Phase ll Study in Patients with Advanced Non-small-Cell Lung Cancer (JO25567): Updated Safety ResultsDrug Safety201758
2. 2
   Optimal management of patients with hepatocellular carcinoma treated with lenvatinibExpert Opinion on Drug Safety201839
3. 3
   Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factorsExpert Opinion on Drug Safety202121
4. 4
   D-dimer for screening of aortic dissection in patients with ST-elevation myocardial infarctionAmerican Journal of Emergency Medicine202211
5. 5
   Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidineExpert Opinion on Drug Safety20204

主要发表期刊